Real-time Estimate
Cboe BZX
01:07:24 2024-05-24 pm EDT
|
5-day change
|
1st Jan Change
|
140.9
USD
|
+0.64%
|
|
-2.33%
|
+2.24%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14,384
|
16,060
|
21,224
|
17,817
|
15,503
|
15,557
|
-
|
-
|
Enterprise Value (EV)
1 |
17,962
|
18,917
|
24,364
|
21,482
|
19,683
|
19,644
|
19,071
|
18,753
|
P/E ratio
|
17
x
|
11.4
x
|
11.1
x
|
19.6
x
|
18.4
x
|
17.9
x
|
16.4
x
|
14.8
x
|
Yield
|
1.99%
|
1.88%
|
1.53%
|
1.69%
|
-
|
2.11%
|
2.13%
|
2.16%
|
Capitalization / Revenue
|
1.86
x
|
1.7
x
|
1.97
x
|
1.8
x
|
1.68
x
|
1.65
x
|
1.59
x
|
1.54
x
|
EV / Revenue
|
2.32
x
|
2
x
|
2.26
x
|
2.17
x
|
2.13
x
|
2.08
x
|
1.95
x
|
1.86
x
|
EV / EBITDA
|
11.6
x
|
7.66
x
|
8.49
x
|
10.4
x
|
11
x
|
10.4
x
|
9.57
x
|
8.94
x
|
EV / FCF
|
21.3
x
|
11.9
x
|
13.3
x
|
16.3
x
|
22.8
x
|
22.2
x
|
17.6
x
|
15.1
x
|
FCF Yield
|
4.69%
|
8.39%
|
7.51%
|
6.12%
|
4.39%
|
4.51%
|
5.68%
|
6.61%
|
Price to Book
|
2.52
x
|
2.34
x
|
3.19
x
|
2.95
x
|
-
|
2.28
x
|
2.09
x
|
1.91
x
|
Nbr of stocks (in thousands)
|
134,697
|
134,766
|
122,675
|
113,887
|
112,435
|
111,092
|
-
|
-
|
Reference price
2 |
106.8
|
119.2
|
173.0
|
156.4
|
137.9
|
140.0
|
140.0
|
140.0
|
Announcement Date
|
1/30/20
|
2/4/21
|
2/3/22
|
2/2/23
|
2/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,726
|
9,437
|
10,788
|
9,883
|
9,252
|
9,447
|
9,762
|
10,098
|
EBITDA
1 |
1,549
|
2,468
|
2,870
|
2,059
|
1,788
|
1,887
|
1,993
|
2,099
|
EBIT
1 |
1,220
|
2,107
|
2,462
|
1,742
|
1,457
|
1,515
|
1,611
|
1,715
|
Operating Margin
|
15.79%
|
22.33%
|
22.82%
|
17.63%
|
15.75%
|
16.03%
|
16.5%
|
16.99%
|
Earnings before Tax (EBT)
1 |
1,076
|
1,884
|
2,599
|
1,235
|
1,130
|
1,198
|
1,285
|
1,399
|
Net income
1 |
858
|
1,431
|
1,995
|
946
|
854
|
894
|
961.6
|
1,050
|
Net margin
|
11.11%
|
15.16%
|
18.49%
|
9.57%
|
9.23%
|
9.46%
|
9.85%
|
10.4%
|
EPS
2 |
6.280
|
10.47
|
15.55
|
7.970
|
7.490
|
7.812
|
8.518
|
9.441
|
Free Cash Flow
1 |
843
|
1,587
|
1,830
|
1,314
|
864
|
886.1
|
1,082
|
1,239
|
FCF margin
|
10.91%
|
16.82%
|
16.96%
|
13.3%
|
9.34%
|
9.38%
|
11.09%
|
12.27%
|
FCF Conversion (EBITDA)
|
54.42%
|
64.3%
|
63.76%
|
63.82%
|
48.32%
|
46.95%
|
54.31%
|
59.05%
|
FCF Conversion (Net income)
|
98.25%
|
110.9%
|
91.73%
|
138.9%
|
101.17%
|
99.12%
|
112.57%
|
118.03%
|
Dividend per Share
2 |
2.120
|
2.240
|
2.640
|
2.640
|
-
|
2.956
|
2.977
|
3.029
|
Announcement Date
|
1/30/20
|
2/4/21
|
2/3/22
|
2/2/23
|
2/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
2,744
|
2,611
|
2,453
|
2,486
|
2,333
|
2,331
|
2,338
|
2,295
|
2,288
|
2,366
|
2,394
|
2,363
|
2,330
|
2,444
|
2,481
|
EBITDA
1 |
659
|
660
|
515
|
504
|
407
|
431
|
473
|
464
|
420
|
436
|
487.2
|
484.5
|
462.1
|
460.6
|
505.6
|
EBIT
1 |
553
|
554
|
435
|
423
|
330
|
350
|
389
|
380
|
338
|
349
|
404.7
|
398.4
|
365
|
373.8
|
430.3
|
Operating Margin
|
20.15%
|
21.22%
|
17.73%
|
17.02%
|
14.14%
|
15.02%
|
16.64%
|
16.56%
|
14.77%
|
14.75%
|
16.9%
|
16.86%
|
15.66%
|
15.29%
|
17.35%
|
Earnings before Tax (EBT)
1 |
502
|
452
|
323
|
351
|
109
|
277
|
317
|
299
|
237
|
266
|
318
|
313
|
286
|
285
|
333.5
|
Net income
1 |
390
|
355
|
234
|
256
|
101
|
202
|
235
|
225
|
192
|
194
|
236
|
232.7
|
207.7
|
211.4
|
251.3
|
Net margin
|
14.21%
|
13.6%
|
9.54%
|
10.3%
|
4.33%
|
8.67%
|
10.05%
|
9.8%
|
8.39%
|
8.2%
|
9.86%
|
9.85%
|
8.92%
|
8.65%
|
10.13%
|
EPS
2 |
3.120
|
2.920
|
1.960
|
2.170
|
0.8700
|
1.780
|
2.050
|
1.960
|
1.700
|
1.720
|
2.069
|
2.055
|
1.837
|
1.896
|
2.265
|
Dividend per Share
2 |
0.6200
|
0.6600
|
0.6600
|
0.6600
|
0.6600
|
0.7100
|
0.7100
|
-
|
-
|
-
|
0.7500
|
0.7500
|
0.7500
|
0.7470
|
0.7744
|
Announcement Date
|
2/3/22
|
4/21/22
|
7/21/22
|
10/20/22
|
2/2/23
|
4/27/23
|
7/26/23
|
10/24/23
|
2/1/24
|
4/23/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,578
|
2,857
|
3,140
|
3,665
|
4,180
|
4,087
|
3,513
|
3,196
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.31
x
|
1.158
x
|
1.094
x
|
1.78
x
|
2.338
x
|
2.165
x
|
1.763
x
|
1.523
x
|
Free Cash Flow
1 |
843
|
1,587
|
1,830
|
1,314
|
864
|
886
|
1,082
|
1,239
|
ROE (net income / shareholders' equity)
|
16.5%
|
24.6%
|
28.4%
|
19.1%
|
14%
|
15.1%
|
14.9%
|
14.9%
|
ROA (Net income/ Total Assets)
|
7.51%
|
11.4%
|
13.2%
|
8.93%
|
6.36%
|
7.02%
|
7.31%
|
7.72%
|
Assets
1 |
11,417
|
12,590
|
15,091
|
10,593
|
13,430
|
12,742
|
13,155
|
13,597
|
Book Value Per Share
2 |
42.40
|
50.80
|
54.20
|
53.10
|
-
|
61.50
|
66.90
|
73.20
|
Cash Flow per Share
2 |
9.140
|
6.780
|
17.40
|
14.60
|
11.30
|
11.60
|
14.60
|
14.70
|
Capex
1 |
400
|
418
|
403
|
404
|
408
|
421
|
428
|
433
|
Capex / Sales
|
5.18%
|
4.43%
|
3.74%
|
4.09%
|
4.41%
|
4.46%
|
4.39%
|
4.29%
|
Announcement Date
|
1/30/20
|
2/4/21
|
2/3/22
|
2/2/23
|
2/1/24
|
-
|
-
|
-
|
Average target price
146.8
USD Spread / Average Target +4.83% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.35% | 15.56B | | +17.70% | 82.59B | | -28.98% | 69.86B | | 0.00% | 26.5B | | +3.06% | 17.29B | | -12.65% | 16.61B | | +74.37% | 13.2B | | +1.15% | 12.75B | | +73.81% | 12.6B | | +2.74% | 12.19B |
Other Healthcare Facilities & Services
|